CANADIAN BURDEN OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO PATHOLOGIC MYOPIA: BASELINE CHARACTERISTICS OF PATIENTS

被引：0
|
作者：
Zaour, N. [1 ]
Heisel, O. [2 ]
Barbeau, M. [1 ]
Ma, P. [3 ]
机构：
[1] Novartis Pharmaceut Canada Inc, Dorval, PQ, Canada
[2] Syreon Corp, Vancouver, BC, Canada
[3] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.1156
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A504 / A504
页数：1
相关论文
共 50 条
  • [21] Lacquer crack formation and choroidal neovascularization in pathologic myopia
    Ikuno, Yasushi
    Sayanagi, Kaori
    Soga, Kaori
    Sawa, Miki
    Gomi, Fumi
    Tsujikawa, Motokazu
    Tano, Yasuo
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2008, 28 (08): : 1124 - 1131
  • [22] Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia
    Ozkiris, Abdullah
    Tuzcu, Esra Ahan
    Erkilic, Kuddusi
    Ilhan, Ozgur
    Oner, Ayse
    Yarbag, Abdulhekim
    Pangal, Emine
    ERCIYES MEDICAL JOURNAL, 2008, 30 (04) : 238 - 241
  • [23] Treatment of choroidal neovascularization in pathologic myopia with intravitreal bevacizumab
    Laud, Ketan
    Spaide, Richard F.
    Freund, K. Bailey
    Slakter, Jason
    Klancnik, James M., Jr.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (08): : 960 - 963
  • [24] Ocular Risk Factors for Choroidal Neovascularization in Pathologic Myopia
    Ikuno, Yasushi
    Jo, Yukari
    Hamasaki, Toshimitsu
    Tano, Yasuo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (07) : 3721 - 3725
  • [25] Nine-Year Outcome of Ranibizumab Monotherapy for Choroidal Neovascularization Secondary to Pathologic Myopia
    Pastore, Marco R.
    Capuano, Vittorio
    Bruyere, Elsa
    Miere, Alexandra
    Corbelli, Eleonora
    Querques, Lea
    Tognetto, Daniele
    Bandello, Francesco
    Querques, Giuseppe
    Souied, Eric H.
    OPHTHALMOLOGICA, 2018, 239 (2-3) : 133 - 142
  • [26] Intravitreal ranibizumab for choroidal neovascularization secondary to pathologic myopia: 12-month results
    Mones, J. M.
    Amselem, L.
    Serrano, A.
    Garcia, M.
    Hijano, M.
    EYE, 2009, 23 (06) : 1276 - 1280
  • [27] Intravitreal bevacizumab for treatment of choroidal neovascularization in pathologic myopia
    Tewari, Asheesh
    Dhalla, Mandeep S.
    Apte, Rajendra S.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (09): : 1093 - 1094
  • [28] Fluorescein Leakage and Optical Coherence Tomography Features of Choroidal Neovascularization Secondary to Pathologic Myopia
    Parodi, Maurizio Battaglia
    Iacono, Pierluigi
    Romano, Francesco
    Bandello, Francesco
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (07) : 3175 - 3180
  • [29] Intravitreal ranibizumab for choroidal neovascularization secondary to pathologic myopia: 12-month results
    J M Monés
    L Amselem
    A Serrano
    M Garcia
    M Hijano
    Eye, 2009, 23 : 1275 - 1281
  • [30] INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION COMPLICATING PATHOLOGIC MYOPIA
    Lalloum, Franck
    Souied, Eric H.
    Bastuji-Garin, Sylvie
    Puche, Nathalie
    Querques, Giuseppe
    Glacet-Bernard, Agnes
    Coscas, Gabriel
    Soubrane, Gisele
    Leveziel, Nicolas
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2010, 30 (03): : 399 - 406
12345